30
Participants
Start Date
December 19, 2023
Primary Completion Date
November 27, 2024
Study Completion Date
November 27, 2025
Cadonilimab+mFOLFIRINOX
"Cadonilimab 6 mg/kg，IVD，D1，Q2W~+mFOLFIRINOX（Oxaliplatin 85 mg/m2 IV over 4 hours ; Irinotecan 150 mg/m2 IV over 90 minutes ; Leucovorin(l-LV) 400 mg/m2 IV over 2 hours 5-fluorouracil 2.4 g/m2 for 46 hours continuous infusion.） on days 2 of a 14-day cycle."
The First Affiliated Hospital with Nanjing Medical University, Nanjing
The First Affiliated Hospital with Nanjing Medical University
OTHER